Literature DB >> 20498323

The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.

Takehiko Mima1, Herbert P Schweizer.   

Abstract

Most Burkholderia pseudomallei strains are intrinsically aminoglycoside resistant, mainly due to AmrAB-OprA-mediated efflux. Rare naturally occurring or genetically engineered mutants lacking this pump are aminoglycoside susceptible despite the fact that they also encode and express BpeAB-OprB, which was reported to mediate efflux of aminoglycosides in the Singapore strain KHW. To reassess the role of BpeAB-OprB in B. pseudomallei aminoglycoside resistance, we used mutants overexpressing or lacking this pump in either AmrAB-OprA-proficient or -deficient strain 1026b backgrounds. Our data show that BpeAB-OprB does not mediate efflux of aminoglycosides but is a multidrug efflux system which extrudes macrolides, fluoroquinolones, tetracyclines, acriflavine, and, to a lesser extent, chloramphenicol. Phylogenetically, BpeAB-OprB is closely related to Pseudomonas aeruginosa MexAB-OprM, which has a similar substrate spectrum. AmrAB-OprA is most closely related to MexXY, the only P. aeruginosa efflux pump known to extrude aminoglycosides. Since BpeAB-OprB in strain KHW was also implicated in playing a major role in export of acylated homoserine lactone (AHL) quorum-sensing molecules and in expression of diverse virulence factors, we explored whether this was also true in the strain 1026b background. The results showed that BpeAB-OprB was not required for AHL export, and mutants lacking this efflux system exhibited normal swimming motility and siderophore production, which were severely impaired in KHW bpeAB-oprB mutants. Biofilm formation was impaired in 1026b Delta(amrRAB-oprA) and Delta(amrRAB-oprA) Delta(bpeAB-oprB) mutants. At present, we do not know why our BpeAB-OprB susceptibility and virulence factor expression results with 1026b and its derivatives are different from those previously published for Singapore strain KHW.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498323      PMCID: PMC2916348          DOI: 10.1128/AAC.01803-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump.

Authors:  Edward W Yu; Gerry McDermott; Helen I Zgurskaya; Hiroshi Nikaido; Daniel E Koshland
Journal:  Science       Date:  2003-05-09       Impact factor: 47.728

Review 2.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

3.  Universal chemical assay for the detection and determination of siderophores.

Authors:  B Schwyn; J B Neilands
Journal:  Anal Biochem       Date:  1987-01       Impact factor: 3.365

Review 4.  Management of melioidosis.

Authors:  Vanaporn Wuthiekanun; Sharon J Peacock
Journal:  Expert Rev Anti Infect Ther       Date:  2006-06       Impact factor: 5.091

5.  Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b.

Authors:  Ayush Kumar; Kim-Lee Chua; Herbert P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

6.  Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei.

Authors:  Kyoung-Hee Choi; Takehiko Mima; Yveth Casart; Drew Rholl; Ayush Kumar; Ifor R Beacham; Herbert P Schweizer
Journal:  Appl Environ Microbiol       Date:  2007-12-21       Impact factor: 4.792

7.  Targeted mutagenesis of Burkholderia thailandensis and Burkholderia pseudomallei through natural transformation of PCR fragments.

Authors:  Metawee Thongdee; Larry A Gallagher; Mark Schell; Tararaj Dharakul; Sirirurg Songsivilai; Colin Manoil
Journal:  Appl Environ Microbiol       Date:  2008-02-29       Impact factor: 4.792

8.  A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants.

Authors:  T T Hoang; R R Karkhoff-Schweizer; A J Kutchma; H P Schweizer
Journal:  Gene       Date:  1998-05-28       Impact factor: 3.688

9.  Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.

Authors:  Paola Guglierame; Maria Rosalia Pasca; Edda De Rossi; Silvia Buroni; Patrizio Arrigo; Giulia Manina; Giovanna Riccardi
Journal:  BMC Microbiol       Date:  2006-07-20       Impact factor: 3.605

10.  Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.

Authors:  Silvia Buroni; Maria R Pasca; Ronald S Flannagan; Silvia Bazzini; Anna Milano; Iris Bertani; Vittorio Venturi; Miguel A Valvano; Giovanna Riccardi
Journal:  BMC Microbiol       Date:  2009-09-17       Impact factor: 3.605

View more
  60 in total

1.  Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.

Authors:  Linnell B Randall; Enrico Georgi; Gelimer H Genzel; Herbert P Schweizer
Journal:  J Antimicrob Chemother       Date:  2017-04-01       Impact factor: 5.790

2.  Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei.

Authors:  Jessica R Webb; Erin P Price; Nawarat Somprasong; Herbert P Schweizer; Robert W Baird; Bart J Currie; Derek S Sarovich
Journal:  Future Microbiol       Date:  2018-09-26       Impact factor: 3.165

3.  Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression.

Authors:  Katherine A Rhodes; Nawarat Somprasong; Nicole L Podnecky; Takehiko Mima; Sunisa Chirakul; Herbert P Schweizer
Journal:  Microbiology       Date:  2018-07-19       Impact factor: 2.777

4.  Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade.

Authors:  Christopher T French; Isabelle J Toesca; Ting-Hsiang Wu; Tara Teslaa; Shannon M Beaty; Wayne Wong; Minghsun Liu; Imke Schröder; Pei-Yu Chiou; Michael A Teitell; Jeff F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

Review 5.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 6.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

7.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

8.  Alteration of the phenotypic and pathogenic patterns of Burkholderia pseudomallei that persist in a soil environment.

Authors:  Yao-Shen Chen; Wun-Ju Shieh; Cynthia S Goldsmith; Maureen G Metcalfe; Patricia W Greer; Sherif R Zaki; Hsin-Hou Chang; Hao Chan; Ya-Lei Chen
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

Review 9.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

10.  Functional characterization of Burkholderia pseudomallei trimeric autotransporters.

Authors:  Cristine G Campos; Matthew S Byrd; Peggy A Cotter
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.